Trial Profile
N-Acetytilcysteine Versus placebo for the prevention of Acute Reduction in Renal function after primary Angioplasty (NoVARA)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2014
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Renal impairment
- Focus Therapeutic Use
- Acronyms NoVARA
- 07 Jul 2014 New trial record